𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A

✍ Scribed by Dr. Paul E. Greene; Stanley Fahn

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
492 KB
Volume
8
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after injection in all 15 patients. Patients were then injected with botulinum toxin type F (botox F) in the same muscles that had been injected with botox A. Ten of the 15 improved after botox F injections, including 9 of the 12 patients who had improved with type A toxin. Six of 9 patients with pain had improvement in pain after botox F injections. Patients reported similar improvement with type F and type A toxins, but duration of benefit was ˜3 months with type A and ˜1 month with type F. Botox F is an effective treatment for torticollis in patients who are immune to botox A. The usefulness of type F toxin, however, is limited by short duration of benefit.

πŸ“œ SIMILAR VOLUMES

Development of resistance to botulinum t
Development of resistance to botulinum toxin type A in patients with torticollis
✍ Dr. Paul Greene; Stanley Fahn; Beverly Diamond πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 453 KB

## Abstract Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of these 559 patients (4.3%) had serological evidence of antibodies to btx by mouse neutralization assay. Some of the 559 patients had only one or two injection se

Secondary nonresponsiveness to botulinum
Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia
✍ Charles H. Adler; Stewart A. Factor; Mitchell Brin; Kapil D. Sethi πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6‐year

BotB (botulinum Toxin type B): Evaluatio
BotB (botulinum Toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-Resistant cervical dystonia patients (preliminary study)
✍ Dr. Daniel D. Truong; Paul A. Cullis; Christopher F. O'Brien; Martin Koller; Tim πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

## Abstract Botulinum toxin (BTX) injection is considered the treatment of choice for patients with cervical dystonia (torticollis). We conducted a pilot, open‐label, dose‐escalation study with BTX type B in 12 patients who no longer responded clinically to injections with BTX type A. At the doses